Back to Results
First PageMeta Content
Pharmacy / Pharmaceuticals policy / Biosimilar / Biotechnology / Drugs / Biologic / Generic drug / Pharmacovigilance / Pharmaceutical industry / Pharmaceutical sciences / Pharmacology / Medicine


18 September 2013 ABNPO Box 222 Pymble BC NSW 2073
Add to Reading List

Document Date: 2013-09-19 11:24:19

Open Document

File Size: 586,02 KB

Share Result on Facebook

City

Kyalami / Amman / Washington / DC / Toronto / Brussels / /

Continent

Europe / /

Country

Taiwan / Italy / South Africa / Belgium / Jordan / Brazil / Canada / Australia / /

/

Facility

Howick Mews / INN Working Doc / Villa No. / /

IndustryTerm

biosimilar pharmaceutical industry / manufacturing changes / biological products / biotechnology products / reference product / biologic product / pharmacovigilance systems / treatment algorithms / post-change products / pharmaceuticals / healthcare professionals / originator product / biosimilar product / healthcare services / biosimilar products / communication chain / therapy for management of diseases / /

MedicalCondition

diseases / /

MedicalTreatment

medication error / biologic therapies / /

Organization

World Health Organization / Japan Generic Medicines Association / Medicines Association of Pharmaceutical Pharmaceutical / Association National Association / Jordanian Association of Pharmaceutical Manufacturers / Therapeutic Goods Administration / National Association of Pharmaceutical Manufacturers / International Generic Pharmaceutical Alliance / Canadian Generic Pharmaceutical Association / European Generic Medicines Association / European Union / /

Person

John Skerritt / Therapeutic Goods / /

/

Position

Governor / Professor / National Manager / /

Product

Remicade / /

ProgrammingLanguage

DC / /

ProvinceOrState

Ontario / /

Technology

alpha / antibodies / biotechnology / treatment algorithms / /

URL

www.gphaonline.org / www.japm.com / www.egagenerics.com / www.napm.co.za / http /

SocialTag